Granulation tissue ingrowth (null)

Granulation tissue ingrowth describes the biological phenomenon where new connective tissue and microscopic blood vessels develop within the base of an open wound during its proliferative phase. This highly vascularized connective tissue consists primarily of proliferating fibroblasts producing extracellular matrix proteins like collagen and elastin; endothelial cells driving angiogenesis; keratinocytes aiding reepithelialization; macrophages orchestrating immune defense and debris clearance; and other inflammatory cells supporting repair processes[1][2][3][5][6]. Healthy granulating wounds appear moist, pink/red with granular texture due to capillary loops. The presence of robust granulating tissue signals effective transition from inflammation toward successful repair. While essential for normal healing—filling dead space in full-thickness injuries—abnormalities such as hypergranular overgrowth or insufficient formation are clinical challenges that may require intervention but do not represent direct druggable targets themselves. Summary judgment: "Granulation tissue ingrowth" should not be treated as a canonical therapeutic target but rather recognized as an important physiological event/process within wound biology.[1][2]

Other names

GranulationGranulation phase (of wound healing)Proliferative phase (context-dependent)

Not applicable for this entry as there is no direct drug-target interaction; mechanisms relate to modulation of inflammation, angiogenesis, fibroblast activity.